title: [New recommendations on the use of human albumin solutions in patients with severe sepsis and septic shock. A critical evaluation of the literature].
abstract: The third edition of the Surviving Sepsis Campaign guidelines opens the door to the use of albumin for fluid resuscitation in patients with severe sepsis and septic shock. This recommendation is based on a recent meta-analysis that included studies with evidence of insufficient plasma expansion in the control group and studies performed in children with malaria with clear statistical heterogeneity (P for interaction=.02). After excluding pediatric studies, the confidence interval of the effect estimate was consistent with a mortality excess in the group treated with albumin (OR=.87 [95%CI: .71 to 1.07]). Two new randomized studies reported after publication of the meta-analysis found no benefit in patients treated with albumin. Given the uncertainty about the true effect of albumin (due to the existence of indirectness and imprecision) and its cost considerations, it is suggested not to use albumin in the initial resuscitation of patients with severe sepsis and septic shock (GRADE2C).
authors.affiliation: Hospital General Universitario de Elche, Elche, Alicante, España. jlatour@coma.es
authors.forename: J
authors.initials: J
authors.lastname: Latour-Pérez
mesh_terms: D000418:Albumins / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D017410:Practice Guidelines as Topic; D018805:Sepsis / Q000188:drug therapy*; D012772:Shock, Septic / Q000188:drug therapy; D012996:Solutions
chemical_list: D000418:Albumins; D012996:Solutions
keywords: Albumin; Albúmina; Clinical practice guidelines; Guías de práctica clínica; Revisión sistemática; Sepsis; Septic shock; Shock séptico; Systematic review